
Aaron D Friedman MD
Laryngology & Voice Disorders
Director, NorthShore University HealthSystem Voice Center
Join to View Full Profile
- 3199 Highland AveCincinnati, OH 45219 
- Phone+1 847-504-3300 
- Fax+1 847-504-3305 
Dr. Friedman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
 Cleveland Clinic FoundationResidency, Otolaryngology - Head and Neck Surgery, 2003 - 2008 Cleveland Clinic FoundationResidency, Otolaryngology - Head and Neck Surgery, 2003 - 2008
 Columbia University Vagelos College of Physicians and SurgeonsClass of 2002 Columbia University Vagelos College of Physicians and SurgeonsClass of 2002
Certifications & Licensure
 OH State Medical License 2002 - 2027 OH State Medical License 2002 - 2027
 KY State Medical License 2021 - 2026 KY State Medical License 2021 - 2026
 IL State Medical License 2012 - 2020 IL State Medical License 2012 - 2020
 MA State Medical License 2007 - 2012 MA State Medical License 2007 - 2012
 American Board of Otolaryngology - Head and Neck Surgery Otolaryngology American Board of Otolaryngology - Head and Neck Surgery Otolaryngology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Fellow (FAAO-HNS) American Academy of Otolaryngology - Head and Neck Surgery
Clinical Trials
- INO-3107 With Electroporation (EP) in Participants With HPV-6- and/or HPV-11-Associated Recurrent Respiratory Papillomatosis (RRP) Start of enrollment: 2020 Jun 15
Publications & Presentations
PubMed
- Dysphagia Outcomes in Zenker Diverticulum: A Longitudinal POuCH Study.Ari D Schuman, Mallory McKeon, Jacqui Allen, Mekibib Altaye, Milan R Amin
 The Laryngoscope. 2025-08-19
- DNA Immunotherapy (INO-3107) Results in Long-Term Surgery Reduction in RRP.Milan R Amin, Peter C Belafsky, Simon R Best, Aaron D Friedman, Adam M Klein
 The Laryngoscope. 2025-08-09
- 5 citationsDNA immunotherapy for recurrent respiratory papillomatosis (RRP): phase 1/2 study assessing efficacy, safety, and immunogenicity of INO-3107.Matthew P Morrow, Elisabeth Gillespie, Albert Sylvester, Milan R Amin, Peter C Belafsky
 Nature Communications. 2025-02-12
Press Mentions
 Data Published in the Laryngoscope Shows INO-3107 Resulted in Long-Term Surgery Reduction in Recurrent Respiratory Papillomatosis (RRP)August 11th, 2025 Data Published in the Laryngoscope Shows INO-3107 Resulted in Long-Term Surgery Reduction in Recurrent Respiratory Papillomatosis (RRP)August 11th, 2025
 Data Published in the Laryngoscope Shows INO-3107 Resulted in Long-Term Surgery Reduction in Recurrent Respiratory Papillomatosis (RRP)August 11th, 2025 Data Published in the Laryngoscope Shows INO-3107 Resulted in Long-Term Surgery Reduction in Recurrent Respiratory Papillomatosis (RRP)August 11th, 2025
 Otolaryngologists Discuss COVID-19 Impact in Live Olympus WebinarJune 25th, 2020 Otolaryngologists Discuss COVID-19 Impact in Live Olympus WebinarJune 25th, 2020
- Join now to see all
Professional Memberships
- Fellow
External Links
- NorthShore University HealthSystem Voice Centerhttp://www.northshore.org/voice
- Voice Surgeonhttp://www.voicesurgeon.net
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









